Category: St. Jude Medical
Medicare regulators finalize new reimbursement coverage for Abbott's MitraClip heart valve device and St. Jude Medical's CardioMEMs heart failure monitoring system.
The Mass. Supreme Judicial Court denies St. Jude Medical's bid to overturn the portions of a lower court's ruling that went against it in its laser technology spat with Volcano Corp.
The highest court in Massachusetts largely denied
Boston Millennia's managing general partner Dana Callow discusses the 11-year journey to bring CardioMEMs implantable heart monitor to market and what his venture capital firm sees for the future of medtech investment.
The CardioMEMS story didn't end when St. Jude Medical (NYSE:STJ) acquired the Georgia-based company in June, paying $375 million for the stake it didn’t already own, valuing the implantable heart failure monitor company at $463 million total.
Here's a look at some of the top legal news stories for medical device companies this week: Judge nixes alleged settlement in Stryker, Biomet poaching spat; Boston Scientific loses bids to exclude testimony in pelvic mesh trials; Occlutech claims another win over St. Jude Medical; Align Tech declares a 'total win' as federal circuit reverses ITC ruling; Report: Medtronic shareholder sues to block Covidien merger
St. Jude Medical informs California state regulators that it's planning to lay off 274 from a facility in Sylmar.
St. Jude Medical (NYSE:STJ) is about to hand out more than 270 pink slips to employees at a facility in Sylmar, Calif., according to a notice filed with the state's Employment Development Dept.
Occlutech says a U.K. court invalidated a patent held by St. Jude Medical covering atrial septal occluder technology.
European approval of next-generation ablation catheter further strengthens St. Jude Medical's fast-growing ablation technology portfolio.